FDA Resources

PEMD-96-8R: Published: Apr 23, 1996. Publicly Released: Apr 23, 1996.

Additional Materials:


Office of Public Affairs
(202) 512-4800

Pursuant to a congressional request, GAO reviewed the Food and Drug Administration's (FDA) resource allocation, workload, and review time for biologics, human drugs, medical devices, food additives, and animal drugs. GAO noted that: (1) the amount of resources needed for each application review varies by product type; (2) in general, review times are shorter for application reviews that require fewer resources; (3) resource allocation also varies by each review center's product mix at any given time; and (4) FDA has initiated a number of changes to increase the efficiency of its product review process, but their effectiveness are not yet known.

Oct 26, 2020

Sep 30, 2020

Sep 10, 2020

Sep 8, 2020

Aug 13, 2020

Jul 29, 2020

Jul 8, 2020

Jun 22, 2020

May 26, 2020

May 12, 2020

Looking for more? Browse all our products here